Then, we performed WB experiments on bladder cancer cell lines with knockdown or overexpression of IGF2BP3 to investigate the expression changes of multiple cyclin proteins CDK2, CDK4, CDK6, and CCND1. This evidence concerns the gene IGF2BP3 and urinary bladder carcinoma.